{"brief_title": "New Antibiotic to Treat Patients With Community-acquired Pneumonia Due to a Specific Bacteria (S. Pneumoniae Pneumonia)", "brief_summary": "This study will treat patients who have a community-acquired pneumonia that is due to a specific bacteria (S. pneumoniae)", "condition": ["Pneumonia, Pneumococcal", "Community Acquired Infections", "Gram-positive Bacterial Infections"], "intervention_type": ["Drug"], "intervention_name": ["Antibiotic"], "criteria": "Other specific inclusion/exclusion criteria may apply. In order to determine eligibility, further examination by the investigator is necessary. Inclusion Criteria: - Patients must have the signs and symptoms of pneumonia, with a chest xray showing a pneumonia. - The patient must have S. pneumoniae (a specific bacteria) growing in sputum or blood to continue treatment. Exclusion Criteria: - Patients cannot have taken more than one day of another antibiotic before entering this study. - Patients with HIV and a low CD4 count are excluded.", "gender": "All", "minimum_age": "13 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "keyword": "Pharmacia", "mesh_term": ["Infection", "Communicable Diseases", "Pneumonia", "Bacterial Infections", "Gram-Positive Bacterial Infections", "Community-Acquired Infections", "Pneumonia, Pneumococcal", "Anti-Bacterial Agents", "Antibiotics, Antitubercular"], "id": "NCT00035269"}